WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'4201 Infant (under 12 months) mortality rate: 252
GDP / capita (US$): 4'9561 Child (under 5 years) mortality rate: 322

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 246'864  243'802  240'676  237'487  234'243  208'939  178'633  145'494 
Births 4'736  4'781  4'821  4'849  4'863  4'505  4'624  4'867 
Surviving infants 4'614  4'654  4'689  4'713  4'723  4'333  4'373  4'493 
Pop. less than 5 years 24'622  25'019  25'074  24'897  24'428  21'029  21'905  21'664 
Pop. less than 15 years 72'329  72'220  71'792  70'799  69'713  64'060  65'054  59'751 
Female 15-49 years 66'144  65'488  64'897  64'334  63'745  57'514  45'242  34'583 

Number of reported case

(Click for retrospective incidence data for Indonesia)
Diphtheria 1'192  806  432  189  219  23  2'200  3'674 
Japanese encephalitis
Measles 15'489  21'893  18'869  20'818  15'369  3'344  92'105  28'935 
Mumps
Pertussis 1'941  973  142  30'014  32'999 
Polio* 35  465  182 
Rubella 1'020  1'959  1'323  2'090  340 
Rubella (CRS)
Tetanus (neonatal) 106  114  147  158  183  466  1'427  954 
Tetanus (total) 210  147  231  183  466  7'784  7'231 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Indonesia)
Vaccine year result method % card seen                                                
BCG 2011  89  DHS   41.1  89  97  97  93  89  87  94  61 
DTP1 2011  88  DHS   41.1  88  93  94  89  86  87 
DTP3 2011  72  DHS   41.1  73  83  83  82  77  77  88 
HepB_BD          80  80  75  68  52  55 
HepB3 2009  62  HHS     73  83  83  82  78  65 
Hib3         
JapEnc         
MCV 2011  80  DHS   41.1  84  89  89  82  83  73  85 
MCV2          81  85  85  85  78 
PCV1         
PCV3         
Pol3 2011  76  DHS   41.1  78  92  93  89  91  74  89 
Rota1         
Rota_last         
Rubella1         
TT2plus 2006  EPI   52.0  70  71  71  73  72  81  61 
PAB         
VAD1          82  83  75  60 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Indonesia)
BCG 81  80  80  78  80  81  74  61 
DTP1 91  90  91  90  89  84  82 
DTP3 64  62  62  62  65  75  60 
HepB3 64  62  62  62  68  65 
Hib3
MCV 80  74  75  74  76  76  58 
PAB 85  85  85  85  79  82  64 
PCV3
Pol3 69  65  66  67  72  72  60 
Rota_last

Number of districts in the country 497  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 12
From 50 to 79% 16
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DT 6 years; Yes
DTwPHep 2, 3, 4 months; Yes
DTwPHibHepB 2, 3, 4 months; No From July 2013
HepB 0-7 days; Yes
IPV 2, 3, 4 months; No
Measles 9 months; 6 years; Yes
OPV 1, 2, 3, 4 months; Yes
Td 7, 8 years; Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2014  2010-2014  2010-2014  2007-2011  2007 - 2011  2007-2011  2002-2006 
Nº of districts with microplans that include activities to raise immunization coverage number 58  497  495  46  464  440  440 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 497  497  495  475  464  440  440 
Nº districts with DTP3 coverage >=80% number 392  397  389  382  367  323  303 
% of districts with DTP3 coverage >=80% From 0 to 100% 79  80  79  80  79  73  69 
Nº districts with measles (MCV1) coverage >=95% number 269  198  197  162  148     
% of districts with MCV1 coverage >=95% From 0 to 100% 54  40  40  34  32     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100    100  100  92  87 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.